ARCHIVES

BRAF Inhibitor Shrank Tumors In Phase II Genentech Study

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

New Technology May Enable Therapy Tailored To Patient’s Predicted Response

April 26, 2002

DCT Board Approves Lung Cancer Drug Discovery Project, First Targeted Anticancer Agent Search

June 22, 1984

National Cancer Policy Board will end in 2005, NCI to support a cancer forum at IOM.

November 5, 2004

Scientists Falsified Research, ORI Says

July 5, 1996

ACS Adopts Principles As Basis For Reform Of Health Care System

July 17, 1992

CPRU Program Gets Basic Concept Approval

October 2, 1987